About this episode

The episode discusses advancements in cancer detection and treatment through genomics and AI.

Cancer is often most treatable when it's found early—but what if we could detect it before symptoms ever appear? Advances in genomics, blood-based biomarkers, and artificial intelligence are giving researchers new ways to identify cancer earlier, understand disease at a deeper level, and move beyond one-size-fits-all treatment approaches. In this conversation, Dr. Scott Penberthy, Dr. Lindsey Cotton, and Dr. Doug Flora explore how emerging technologies are reshaping cancer detection, precision medicine, drug discovery, and clinical decision-making. They discuss the growing role of multimodal AI, the promise of next-generation sequencing, and why the future of healthcare may depend on finding patterns humans simply cannot see on their own. The goal isn't just better technology—it's earlier intervention, more personalized care, and better outcomes for patients.

People in this episode

Guests: Dr. Scott Penberthy, Dr. Lindsey Cotton, Dr. Doug Flora

Topics covered

• cancer detection
• genomics
• artificial intelligence
• precision medicine
• biomarkers
• clinical decision-making

Keywords

• cancer
• early detection
• AI
• biomarkers
• precision medicine
• genomics
• drug discovery

Explore listener stats, chart rankings, contacts and more on the AI and Healthcare podcast page.